Affordable Access

CNS sites cooperate to detect duplicate subjects with a clinical trial subject registry.

Authors
  • Shiovitz, Thomas M
  • Wilcox, Charles S
  • Gevorgyan, Lilit
  • Shawkat, Adnan
Type
Published Article
Journal
Innovations in clinical neuroscience
Publication Date
Feb 01, 2013
Volume
10
Issue
2
Pages
17–21
Identifiers
PMID: 23556138
Source
Medline
Keywords
License
Unknown

Abstract

The use of a clinical trial subject registry and cooperation between central nervous system trial sites can reduce the number of duplicate and professional subjects entering clinical trials. To be fully effective, a trial subject database could be integrated into protocols across pharmaceutical companies, thereby mandating site participation and increasing the likelihood that duplicate subjects will be removed before they enter (and negatively affect) clinical trials.

Report this publication

Statistics

Seen <100 times